Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Opioids and breast cancer recurrence: A Danish population-based cohort study.
Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen PM, Ejlertsen B, Sjøgren P, Kehlet H, Sørensen HT. Cronin-Fenton DP, et al. Among authors: ejlertsen b. Cancer. 2015 Oct 1;121(19):3507-14. doi: 10.1002/cncr.29532. Epub 2015 Jul 24. Cancer. 2015. PMID: 26207518 Free PMC article.
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE; Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group; Bernstein JL. Bertelsen L, et al. Among authors: ejlertsen b. J Natl Cancer Inst. 2008 Jan 2;100(1):32-40. doi: 10.1093/jnci/djm267. Epub 2007 Dec 25. J Natl Cancer Inst. 2008. PMID: 18159070
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Kristensen B, Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Bjerregaard B, Cold S, Edlund P, Ewertz M, Kamby C, Lindman H, Nordenskjöld B, Bergh J. Kristensen B, et al. Among authors: ejlertsen b. Acta Oncol. 2008;47(4):740-6. doi: 10.1080/02841860801964988. Acta Oncol. 2008. PMID: 18465343 Clinical Trial.
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.
Willemoe GL, Hertel PB, Bartels A, Jensen MB, Balslev E, Rasmussen BB, Mouridsen H, Ejlertsen B, Brünner N. Willemoe GL, et al. Among authors: ejlertsen b. Eur J Cancer. 2009 Sep;45(14):2528-36. doi: 10.1016/j.ejca.2009.05.029. Epub 2009 Jun 15. Eur J Cancer. 2009. PMID: 19535243 Clinical Trial.
270 results